04.01.2021
Corona vaccine Comirnaty® (BNT162b2) from Pfizer/BioNTech: up to 6 doses per vial possible
01.01.2021
The required tools have been available for years
19.12.2020
Vaccine from Pfizer/BioNTech authorised in the rolling review procedure after close scrutiny of the risks and benefits
11.12.2020
The safety of the Swiss population has top priority
08.12.2020
ICMRA recommends continued follow-up of study subjects in clinical trials of the SARS-CoV2 vaccine
07.12.2020
Swissmedic is examining Janssen’s COVID-19 vaccine in a rolling submission procedure
04.12.2020
The medicines regulators within the Access Consortium will only authorise vaccines if their benefits outweigh the risks
03.12.2020
Eingabefrist: 22. Januar 2021
20.11.2020
Swissmedic inspection uncovers Good Manufacturing Practice (GMP) deficiencies